Literature DB >> 1611788

Tc-99m HMPAO labeled WBC scan for the detection of myocarditis in different phases of Kawasaki disease.

C H Kao1, K S Hsieh, Y L Wang, C W Chen, S Q Liao, S J Wang, S H Yeh.   

Abstract

Myocardial imaging with Tc-99m HMPAO WBC was used to detect myocarditis of Kawasaki disease in 103 infants and children (66 boys and 37 girls, mean age 3 years and 4 months). The clinical course of Kawasaki disease may be divided into three phases, from the onset of illness onset until all clinical symptoms and signs have disappeared. Twenty-four hour myocardial imaging was performed in anterior, LAO, and left lateral views. The grading system was as follows: score 0 less than bone uptake; 1 = bone uptake; 2 greater than bone uptake; and 3 greater than or equal to liver uptake. If the score was greater than or equal to 2, significant myocarditis was considered. The appearing ratio of myocarditis was 57% (13/23) in the first phase; 65% (15/23) in the second phase; 54% (31/57) in the third phase. No significant difference was demonstrated among the three groups of patients (P greater than 0.1, by Chi-square test). In conclusion, an occult myocarditis may continue in all three phases of Kawasaki disease, even if the clinical symptoms and signs had improved by the evidence of Tc-99m HMPAO labeled WBC scan to avoid advanced cardiac complication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611788     DOI: 10.1097/00003072-199203000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

1.  Evaluation of myocardial function by pulsed tissue Doppler in Kawasaki disease.

Authors:  Hamid Amoozgar; Somaieh Mehdizadeh; Gholamhossein Ajami; Soheila Alyasin; Mohammad Borzoee; Saeed Abtahi; Siros Cheriki
Journal:  Pediatr Cardiol       Date:  2009-06-16       Impact factor: 1.655

2.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

3.  Relationships between coronary artery dilatation and severity of carditis detected by two-dimensional echocardiography and [99mTc]HMPAO-labeled white blood cell heart scan in children with Kawasaki disease.

Authors:  C H Kao; K S Hsieh; Y C Chen; Y L Wang; S J Wang
Journal:  Pediatr Radiol       Date:  1994

4.  Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence.

Authors:  Konstantinos Bratis; Pauline Hachmann; Nicholas Child; Thomas Krasemann; Tarique Hussain; Sophie Mavrogeni; Rene Botnar; Reza Razavi; Gerald Greil
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

Review 5.  A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance.

Authors:  Audrey Dionne; Nagib Dahdah
Journal:  Children (Basel)       Date:  2018-10-12

6.  Myocardial fibrosis in patients with a history of Kawasaki disease.

Authors:  Susan M Dusenbery; Jane W Newburger; Steven D Colan; Kimberlee Gauvreau; Annette Baker; Andrew J Powell
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-18

Review 7.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.